Abstract

Adiponectin is gaining renewed interest since, in addition to its possible protective role against insulin resistance and arteriosclerosis, recent studies suggest other additional favorable effects. However, the influence of gene-diet interactions on plasma adiponectin levels is still little understood. We analyzed the association between plasma adiponectin levels and various metabolic traits in a high-cardiovascular risk Mediterranean population, as well as the genetic effect of four candidate single-nucleotide polymorphisms (SNPs) in the adiponectin gene (ADIPOQ) and their interactions with the Mediterranean dietary pattern. Additionally, we explored, at the genome-wide level, the SNPs most associated with plasma adiponectin levels, as well as gene–diet interactions with the Mediterranean diet. In the 954 participants studied (aged 55–80 years), plasma adiponectin levels were strongly associated with plasma HDL-C concentrations (p = 6.6 × 10−36) and inversely related to triglycerides (p = 4.7 × 10−18), fasting glucose (p = 3.5 × 10−16) and type 2 diabetes (p = 1.4 × 10−7). Of the four pre-selected ADIPOQ candidate SNPs, the one most associated with plasma adiponectin was the −11391G > A (rs17300539) promoter SNP (p = 7.2 × 10−5, in the multivariable adjusted model). No significant interactions with the Mediterranean diet pattern were observed for these SNPs. Additionally, in the exploratory genome-wide association study (GWAS), we found new SNPs associated with adiponectin concentrations at the suggestive genome-wide level (p < 1 × 10−5) for the whole population, including the lead SNP rs9738548 (intergenic) and rs11647294 in the VAT1L (Vesicle Amine Transport 1 Like) gene. We also found other promising SNPs on exploring different strata such as men, women, diabetics and non-diabetics (p = 3.5 × 10−8 for rs2850066). Similarly, we explored gene–Mediterranean diet interactions at the GWAS level and identified several SNPs with gene–diet interactions at p < 1 × 10−5. A remarkable gene–diet interaction was revealed for the rs2917570 SNP in the OPCML (Opioid Binding Protein/Cell Adhesion Molecule Like) gene, previously reported to be associated with adiponectin levels in some populations. Our results suggest that, in this high-cardiovascular risk Mediterranean population, and even though adiponectin is favorably associated with metabolic traits and lower type 2 diabetes, the gene variants more associated with adiponectin may be population-specific, and some suggestive gene–Mediterranean diet interactions were detected.

Highlights

  • As we did not observe a top-ranked signal for single-nucleotide polymorphisms (SNPs) in the ADIPOQ and CDH13 candidate genes, we examined the specific associations of these SNPs in the genome-wide association study (GWAS)

  • The robust linear inverse association between plasma adiponectin concentrations and type 2 diabetes risk observed in our population, mainly in women, is concordant with other reports where associations with adiponectin levels were stronger in individuals with a higher metabolic risk profile [77,78,79], supporting the idea that the association between adiponectin concentrations and type 2 diabetes is stronger in subjects with higher body mass index (BMI)

  • We set out to analyze the associations between four well-known candidate SNPs in the ADIPOQ gene and plasma adiponectin levels, subsequently carrying out an exploratory GWAS, given that very few reports have focused on Mediterranean subjects and it is known that even though specific GWAS-population associations may exist, they can misestimate across global populations [83,84]

Read more

Summary

Introduction

Since the discovery of adiponectin in 1995 [1], this hormone, mainly secreted by the adipose tissue and initially called adipocyte complement-related protein of 30 kDa (Acrp30), has drawn a great deal of attention due to its possible protective effect against type 2 diabetes, its anti-inflammatory effects and its anti-atherogenic properties [2,3,4,5].It has aroused controversy, given that various studies reported that high plasma adiponectin levels were associated with lower cardiovascular disease risk [6,7,8,9], others were unable to confirm its protective effect against cardiovascular diseases or total mortality [10,11,12].Given the interest that adiponectin has aroused, there is a large number of studies that have analyzed its associations with various adiposity parameters, insulin resistance, plasma lipid levels, inflammatory markers, type 2 diabetes risk and atherosclerosis biomarkers [13,14,15,16,17,18]. Since the discovery of adiponectin in 1995 [1], this hormone, mainly secreted by the adipose tissue and initially called adipocyte complement-related protein of 30 kDa (Acrp30), has drawn a great deal of attention due to its possible protective effect against type 2 diabetes, its anti-inflammatory effects and its anti-atherogenic properties [2,3,4,5] It has aroused controversy, given that various studies reported that high plasma adiponectin levels were associated with lower cardiovascular disease risk [6,7,8,9], others were unable to confirm its protective effect against cardiovascular diseases or total mortality [10,11,12]. Adiponectin levels may have an important genetic component [27,28,29,30,31]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.